Medeniyet University Goztepe Training and Research Hospital.

Kadiköy 34722

0 studies enrolling now · 2 studies all time

What they study most

Crohn Disease, Non-small Cell Lung Cancer (NSCLC)

Studies at this site

• A Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Participants With Previously Untreated Advanced Non-Squamous Non-Small Cell Lung Cancer — Completed
• Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 — Stopped early